Amy Clarke

Amy Clarke

Auto-generated profile, based on publicly available information

Amy Clarke

Institute of Pharmacology, Medical University of Vienna, Vienna, Austria

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2024 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
SSSamin A. Sajan
Samin A. Sajan
RGRalph Gradisch
Ralph Gradisch
FVFlorian D. Vogel
Florian D. Vogel
ACAlison J. Coffey
Alison J. Coffey
DSDaria Salyakina
Daria Salyakina
MKMartin Krenn
Martin Krenn
Nine out of 19 genes encoding GABAA receptor subunits have been linked to monogenic syndromes characterized by seizures and developmental disorders. Previously, we reported the de novo variant p.(Thr300Ile) in GABRA4 in a patient with epilepsy and neurodevelopmental abnormalities. However, no new cases have been reported since then. Through an international collaboration, we collected molecular and phenotype data of individuals carrying de novo variants in GABRA4. Patients and their parents were investigated either by exome or genome sequencing, followed by targeted Sanger sequencing in some cases. All variants within the transmembrane domain, including the previously reported p.(Thr300Ile) variant, were characterized in silico and analyzed by molecular dynamics (MD) simulation studies. We identified three novel de novo missense variants in GABRA4 (NM_000809.4): c.797 C > T, p.(Pro266Leu), c.899 C > A, p.(Thr300Asn), and c.634 G > A, p.(Val212Ile). The p.(Thr300Asn) variant impacts the same codon as the previously reported variant p.(Thr300Ile) and likely arose post-zygotically as evidenced by sequencing oral mucosal cells. Overlapping phenotypes among affected individuals included developmental delay (4/4), epileptiform EEG abnormalities (3/4), attention deficits (3/4), seizures (2/4), autistic features (2/4) and structural brain abnormalities (2/4). MD simulations of the three variants within the transmembrane domain of the receptor indicate that sub-microsecond scale dynamics differ between wild-type and mutated subunits. Taken together, our findings further corroborate an association between GABRA4 and a neurological phenotype including variable neurodevelopmental, behavioral and epileptic abnormalities.

18 June 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
ACAmy Clarke
Amy Clarke
JSJulia Skerjanz
Julia Skerjanz
MGMatthias Gsell
Matthias Gsell
PWPatrick Wiedner
Patrick Wiedner
HEHazel Erkan-Candag
Hazel Erkan-Candag
OTOleksandra Tiapko
Oleksandra Tiapko
The transient receptor potential canonical type 3 (TRPC3) channel plays a pivotal role in regulating neuronal excitability in the brain via its constitutive activity. The channel is intricately regulated by lipids and has previously been demonstrated to be positively modulated by PIP2. Using molecular dynamics simulations and patch clamp techniques, we reveal that PIP2 predominantly interacts with TRPC3 at the L3 lipid binding site, located at the intersection of pre-S1 and S1 helices. We demonstrate that PIP2 sensing involves a multistep mechanism that propagates from L3 to the pore domain via a salt bridge between the TRP helix and S4-S5 linker. Notably, we find that both stimulated and constitutive TRPC3 activity require PIP2. These structural insights into the function of TRPC3 are invaluable for understanding the role of the TRPC subfamily in health and disease, in particular for cardiovascular diseases, in which TRPC3 channels play a major role.

15 April 2026 in Nature Communications
Verified
Journal Article
Open access
TEThijs W. Ettema
Thijs W. Ettema
SISatomi Inaba-Inoue
Satomi Inaba-Inoue
CTChancievan Thangaratnarajah
Chancievan Thangaratnarajah
LSLeticia Alves da Silva
Leticia Alves da Silva
NSNikas Senning
Nikas Senning
KBKonstantinos Beis
Konstantinos Beis
SbmA is a membrane transporter from Escherichia coli that imports antimicrobial peptides. SbmA belongs to the SbmA-like peptide transporter (SLiPT) family. Although the protein is a secondary active transporter that is energized by the proton gradient, it is structurally related to the transmembrane domain (TMD) of ATP-binding cassette (ABC) transporters. SbmA therefore bridges the structural divide between primary and secondary transporters. However, it remains unclear, if SbmA also shares the mechanism of alternating access with ABC transporters, because only a single (outward-open) state is resolved. Here, we show by sequence analysis that SbmA is likely evolved from the TMD of an early ancestor of the ABC transporter YddA. We determine the cryogenic electron microscopy structures of SbmA in occluded and inward-facing states. These conformations closely resemble equivalent states found in ABC transporters, indicating a shared structural mechanism of transport. In contrast to ABC transporters, where nucleotide binding, hydrolysis and release steer conformational changes necessary for substrate translocation, electron paramagnetic resonance (EPR) spectroscopy and molecular dynamics (MD) simulations reveal how pH changes induce conformational transitions in SbmA, consistent with a mechanism of substrate internalization that utilizes the transmembrane proton gradient.

3 February 2025 in Research Square
Verified
Preprint
Open access
PDF file
KBKonstantinos Beis
Konstantinos Beis
TEThijs Ettema
Thijs Ettema
SISatomi Inaba-Inoue
Satomi Inaba-Inoue
CTChancievan Thangaratnarajah
Chancievan Thangaratnarajah
LSLeticia Alves da Silva
Leticia Alves da Silva
DSDirk Jan Slotboom
Dirk Jan Slotboom
SbmA is a membrane transporter from Escherichia coli that imports antimicrobial peptides. Although the protein is a secondary transporter that is energized by the proton gradient, it is structurally related to the transmembrane domain (TMD) of ATP-binding cassette (ABC) transporters. SbmA therefore bridges the structural divide between primary and secondary transporters. However, it remained unclear, if SbmA also shares the mechanism of alternating access with ABC transporters, because only a single (outward-open) state has been resolved. Here, we show by sequence analysis that SbmA has likely evolved from the TMD of an early ancestor of the ABC transporter YddA. We determined the cryogenic electron microscopy structures of SbmA in occluded and inward-facing states. These conformations closely resemble equivalent states found in ABC transporters, indicating a shared structural mechanism of transport. In contrast to ABC transporters, where nucleotide binding, hydrolysis and release steer conformational changes necessary for substrate translocation, electron paramagnetic resonance (EPR) spectroscopy and molecular dynamics (MD) simulations reveal how pH changes induce conformational transitions in SbmA, consistent with a mechanism of substrate internalization that utilizes the transmembrane proton gradient.